From January 1, 2024 to March 31, 2024, the company has repurchased 310,912 shares, representing 0.23% for CNY 14.91 million. With this, the company has completed the repurchase of 607,326 shares, representing 0.45% for CNY 34.9 million under the buyback announced on November 13, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35.36 CNY | -1.81% | +8.77% | -48.29% |
Apr. 02 | Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023. | CI |
Mar. 14 | China Healthcare Stocks Rally on Hopes for Government Support | DJ |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.29% | 670M | |
-3.22% | 102B | |
+1.59% | 96.29B | |
+2.13% | 22.18B | |
-15.74% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.83% | 16.36B | |
+5.32% | 13.97B | |
+33.88% | 12.17B |
- Stock Market
- Equities
- 688202 Stock
- News Shanghai Medicilon Inc.
- Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.